23rd February 2016 Content supplied by: MarketResearchReports.biz
Market Report on U.S. Microbial Identification Industry
This new market study on the U.S. microbial identification industry presents a detailed assessment of the U.S. identification industry, taking various industry aspects such as the production capacity, product pricing, revenue generated, the growth rate, and the dynamics of demand and supply into consideration.
According to the research study, the increasing prevalence of infectious diseases in the U.S. has heightened the need for microbial identification in the country. The rising concerns of U.S. citizens over food safety have also fueled this industry considerably over the previous few years.
In the coming years, the availability of a state-of-the-art healthcare infrastructure, the high disposable income of people, and various initiatives by the U.S. FDA to encourage microbial identification in the U.S. healthcare sector are likely to propel the microbial identification industry in this nation, states the research study.
The report further states that although this industry has received heavy funding from the U.S. government, the complex regulatory framework and the high cost associated with automated microbial identification systems are likely to hamper the growth of this industry in the coming years. However, the rising application of microbial identification systems in bioterrorism surveillance is anticipated to present an opportunity-rich market to participants over the next few years, says the report.
The report studies the U.S. industry for microbial identification on the basis of product type and application. Based on the type of product, the microbial identification industry in the U.S. has been segmented into consumables, instruments and software, and services.
By application, this industry has been classified into diagnostics, pharmaceuticals, environmental application, and food and beverage testing. The diagnostics segment has been further categorized into the diagnosis of humans and the diagnosis of animals in this study.
The research report also examines the U.S. industry for microbial identification on the basis of its competitive landscape. It analyzes the company profiles of major industry participants in order to present the market hierarchy.
Biomerieux SA, Becton, Dickinson and Co., Siemens Healthcare, Biolog Inc., Bruker Corp., Shimadzu Corp., Thermo Fisher Scientific Inc., Qiagen N.V., MIDI Inc., Charles River Laboratories Inc., Hengxing Tech, Tiandiren Bio-tech, Hangzhou Binhe Microorgan, Scenker, Bioyong Tech, and Huizhou Sunshine Bio are the key players in this industry mentioned in this study. Major strategies and future prospects of these players have also been discussed at length in this research report.
To order report Call Toll Free: 866-997-4948 or send an email to email@example.com
Click here to receive a sample copy: www.marketresearchreports.biz/sample/sample/557874
Date Published: 23rd February 2016
Source article link: View
Simultaneous 96-well Extraction of Urine
ELISA/IIFT Serological Diagnostic Test